Takeda Pharmaceutical Company Limited Borrowing Costs Recognised As Expense
Takeda Pharmaceutical Company Limited (TKPHF) reported Borrowing Costs Recognised As Expense of JPY 0 for the 12-month period ending 2021-03-31, per its 20-F filed 2021-06-29.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:BorrowingCostsRecognisedAsExpense · last filed 2021-06-29
| Period end | Borrowing Costs Recognised As Expense 12 month |
|---|---|
| 2021-03-31 | 0.00 JPY 20-F · filed 2021-06-29 |
| 2020-03-31 | 0.00 JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 16.10B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 0.00 JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 0.00 JPY 20-F · filed 2019-06-27 |